Topic
2025 NSCLC Creator Weekend™
9 Podcasts • 8 Cases • 2 Courses on BackTable
Episode # 599 • 19 Dec 2025
Lung Ablation: Techniques, Challenges & Best Practices
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central lung lesions that were previously untreatable. This episode of the 2025 NSCLC Creator Weekend™ series offers a deep dive into recent advancements in lung ablation and brachytherapy techniques for primary lung cancer.
This podcast is supported by an educational grant from Johnson & Johnson and Varian.
More on 2025 NSCLC Creator Weekend™
Loading recent podcasts…
Vascular & IR # 599
Dec 18, 2025
with Dr. Scott Oh, Dr. Alan Lee, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central...
1,500+ listens
Vascular & IR # 597
Dec 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look...
1,300+ listens
Tumor Board # 38
Dec 1, 2025
with Dr. Scott Oh, Dr. Alan Lee, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Collaboration between interventional radiology and radiation oncology has enabled high-dose brachytherapy in central...
Tumor Board # 36
Nov 17, 2025
with Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
How do leading oncologists interpret the abundance of molecular tests, genomic data, and biomarkers to create a lung...
Tumor Board # 40
Dec 15, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft, Dr. Scott Oh
Is the open thoracotomy becoming outdated as robotic surgery and advanced ablation techniques take center stage in lung...
Tumor Board # 39
Dec 8, 2025
with Dr. Robert Suh, Dr. Scott Oh, Dr. Alan Lee, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might simultaneous ablation and biopsy be the new standard for high-probability lung cancer cases where surgery...
Tumor Board # 37
Nov 24, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft, Dr. Venkatesh Krishnasamy
Why might the standard RECIST criteria fail to accurately track success after tumor ablation, and what should you look...
Vascular & IR # 589
Nov 13, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh, Dr. Alan Lee
As lung cancer treatments become more complex, is a collaborative tumor board more essential than ever? We’re kicking...
1,500+ listens
VI Case
Nov 20, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
VI Case
Nov 20, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Dec 15, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Nov 24, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Nov 20, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Dec 15, 2025
with Dr. Venkatesh Krishnasamy, Dr. Scott Atay, Dr. Scott Genshaft and Dr. Scott Oh
Tumor Board Case
Nov 24, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 10, 2025
with Dr. Scott Genshaft, Dr. Karen Reckamp, Dr. Scott Atay, Dr. Scott Oh and Dr. Alan Lee
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.